No image published for this recall

No image published for this recall

Hikma Pharmaceuticals - safety alert

Official notice

22 Jan 2020

Last checked

22 Jan 2020

Critical riskFDA

An official FDA notice concerns Hikma Pharmaceuticals - safety alert. An official FDA notice concerns Hikma Pharmaceuticals. The notice reports a serious safety risk. Follow the official notice for consumer instructions. Published 2020-01-22. Lots: 038366. Recall numbers: D-0864-2020. Check the official notice for the complete list. Published 2020-01-22.

What to do now

The source does not provide specific consumer instructions. Follow the official FDA notice for next steps.

Units affected

101,710

Recall number

D-0864-2020

Official notice

2020-01-22

The hazard

An official FDA notice concerns Hikma Pharmaceuticals. The notice reports a serious safety risk. Follow the official notice for consumer instructions. Published 2020-01-22. Lots: 038366. Recall numbers: D-0864-2020. Check the official notice for the complete list.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Lots

038366

Event Ids

84534

Recall Numbers

D-0864-2020

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

US · United States · NJ · Cherry Hill

Affected area 1

US · United States · NJ · Cherry Hill

Affected area 2

US · United States

Company & contacts

Manufacturer

Not provided

Phone

Not provided

Brand: Hikma Pharmaceuticals. Contact: Hikma Pharmaceuticals USA Inc..

Source & status

Source

Tier

official

Category

HEALTH

App estimate

critical

Recall details

Recall number

D-0864-2020

Event id

84534

Units affected

101,710

Status

terminated

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

US
No image published for this recall

a product listed in the official notice - safety alert

Medium riskFDA6 Aug 2025
US
a product listed in the official notice - safety alertImage: FDA recall notice

a product listed in the official notice - safety alert

Risk not stated by sourceFDA3 Sept 2026
US
70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container - safety alertImage: FDA recall notice

70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container - safety alert

Risk not stated by sourceFDA25 Aug 2026
US
Excel® Lactated Ringers Injection, 1000mL - safety alertImage: FDA recall notice

Excel® Lactated Ringers Injection, 1000mL - safety alert

Risk not stated by sourceFDA19 Aug 2026
US
OPTIRAY Imaging Bulk Package (IBP) 350, 500mL in vial (Ioversol Injection 74% 350 mg iodine/ml) - safety alertImage: FDA recall notice

OPTIRAY Imaging Bulk Package (IBP) 350, 500mL in vial (Ioversol Injection 74% 350 mg iodine/ml) - safety alert

Medium riskFDA4 Aug 2026
US
Cyclophosphamide for Injection - safety alertImage: FDA recall notice

Cyclophosphamide for Injection - safety alert

Medium riskFDA24 Jul 2026

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 22 Jan 2020. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.